1 Min Read
Nov 7 (Reuters) - Karolinska Development AB :
* Karolinska Development company Modus Therapeutics granted U.S. patents for sickle cell disease drug candidate sevuparin
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.